Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Researchers Develop Drug Delivery Superior To Chemo

This article was originally published in PharmAsia News

Executive Summary

Researchers in Japan say they have developed a substitute for chemotherapy, one capable of delivering drugs to targeted cancers. The development is seen as an advantage for treating cancers such as breast and ovarian, which have fewer blood vessels used by chemotherapy to do its work. The researchers found that tumor blood vessels differ from normal ones, featuring tiny gaps that could be exploited to deliver a drug. The result could lead to lower amounts of a drug doing the same job more effectively, and with fewer side effects. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068182

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel